Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (23)

2025

  1. Metagenomic symphony of the intestinal ecosystem: How the composition affects the mind

    Brain, Behavior, and Immunity, Vol. 123, pp. 510-523

2024

  1. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes

    Translational Psychiatry, Vol. 14, Núm. 1

2023

  1. A network analysis investigating the associations between posttraumatic stress symptoms, markers of inflammation and metabolic syndrome

    Journal of Psychiatric Research, Vol. 165, pp. 105-114

  2. Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review

    Journal of Neuroimmunology, Vol. 382

  3. The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles

    Gut microbes, Vol. 15, Núm. 1, pp. 2162306

2022

  1. Editorial: The oral microbiota in mental health

    Frontiers in Psychiatry

2021

  1. 5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

    ACS Chemical Neuroscience, Vol. 12, Núm. 11, pp. 2036-2044

2020

  1. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System

    Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715

2019

  1. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation

    Molecular Neurobiology, Vol. 56, Núm. 1, pp. 553-566

2018

  1. Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4745-4762

2017

  1. Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation

    ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401

  2. The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors

    Cerebral Cortex, Vol. 27, Núm. 5, pp. 2809-2819

2016

  1. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  2. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor

    Neuropharmacology, Vol. 111, pp. 47-58

  3. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration

    Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338

2015

  1. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures

    Oncotarget, Vol. 6, Núm. 28, pp. 25452-25465

  2. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

    Cancer Cell, Vol. 28, Núm. 2, pp. 170-182

2014

  1. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of down syndrome

    PLoS ONE, Vol. 9, Núm. 9

  2. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3776-3794

2013

  1. Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication

    Neural Plasticity, Vol. 2013